Besides supporting the possibility of using this compound for treating oral cancer, the neutralization of IL-6 induced by S100A9 may also function as potent anti-neoplastic agents in oral carcinogenesis, in which the stromal S100A9 plays a significant role in regulating tumor growth and metastasis. This evidence concerns the gene IL6 and lip and oral cavity carcinoma.